检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2013年
17期
2272-2273,2276
,共3页
准分子激光角膜上皮瓣下磨镶术%近视%丝裂霉素C%角膜上皮下雾状混浊
準分子激光角膜上皮瓣下磨鑲術%近視%絲裂黴素C%角膜上皮下霧狀混濁
준분자격광각막상피판하마양술%근시%사렬매소C%각막상피하무상혼탁
eximer laser epithelial keratomileusis%myopia%mitomycin C%corneal haze
目的观察丝裂霉素在准分子激光矫正近视手术中的临床疗效和安全性。方法对照研究将812眼随机分为术中使用丝裂霉素与不使用丝裂霉素组,术后随访两组患者的刺激症状,角膜上皮生长情况,术后视力,验光,眼压和haze情况并进行总结。结果所有病例均按预期完成手术。随诊时间3个月至3年,两组刺激症状较轻,多发生在手术后第1天,一般术后第2天就会好转,术后第3天检查,实验组有40眼为1~2级刺激症状,对照组有38眼为1~2级刺激症状,两组差异无统计学意义(P>0.05)。两组角膜上皮完全愈合时间为3~5d,其中实验组平均为(3.75±0.72)d,对照组平均为(3.54±0.85)d,两组差异无统计学意义(P>0.05)。3~5d摘镜时,实验组有382眼(94.1%),对照组有396眼(97.5%),角膜上皮愈合良好。术后3个月检查,实验组术后视力满意为390眼(93.6%),对照组为344眼(84.7%),两组差异有统计学意义(P<0.05)。术后3个月检查,屈光度较术后3个月时回退超过0.50D,丝裂霉素组有22眼(5.4%),对照组有46眼(11.3%)。术后3月检查,实验组有336眼(82.8%)为0级haze,对照组有252眼(62.1%)为0级haze,两组差异有统计学意义(P<0.05)。结论在准分子矫正近视手术中,一次性应用0.2g/L丝裂霉素可以减轻术后haze的反应,减少术后视力的回退,无明显不良反应。
目的觀察絲裂黴素在準分子激光矯正近視手術中的臨床療效和安全性。方法對照研究將812眼隨機分為術中使用絲裂黴素與不使用絲裂黴素組,術後隨訪兩組患者的刺激癥狀,角膜上皮生長情況,術後視力,驗光,眼壓和haze情況併進行總結。結果所有病例均按預期完成手術。隨診時間3箇月至3年,兩組刺激癥狀較輕,多髮生在手術後第1天,一般術後第2天就會好轉,術後第3天檢查,實驗組有40眼為1~2級刺激癥狀,對照組有38眼為1~2級刺激癥狀,兩組差異無統計學意義(P>0.05)。兩組角膜上皮完全愈閤時間為3~5d,其中實驗組平均為(3.75±0.72)d,對照組平均為(3.54±0.85)d,兩組差異無統計學意義(P>0.05)。3~5d摘鏡時,實驗組有382眼(94.1%),對照組有396眼(97.5%),角膜上皮愈閤良好。術後3箇月檢查,實驗組術後視力滿意為390眼(93.6%),對照組為344眼(84.7%),兩組差異有統計學意義(P<0.05)。術後3箇月檢查,屈光度較術後3箇月時迴退超過0.50D,絲裂黴素組有22眼(5.4%),對照組有46眼(11.3%)。術後3月檢查,實驗組有336眼(82.8%)為0級haze,對照組有252眼(62.1%)為0級haze,兩組差異有統計學意義(P<0.05)。結論在準分子矯正近視手術中,一次性應用0.2g/L絲裂黴素可以減輕術後haze的反應,減少術後視力的迴退,無明顯不良反應。
목적관찰사렬매소재준분자격광교정근시수술중적림상료효화안전성。방법대조연구장812안수궤분위술중사용사렬매소여불사용사렬매소조,술후수방량조환자적자격증상,각막상피생장정황,술후시력,험광,안압화haze정황병진행총결。결과소유병례균안예기완성수술。수진시간3개월지3년,량조자격증상교경,다발생재수술후제1천,일반술후제2천취회호전,술후제3천검사,실험조유40안위1~2급자격증상,대조조유38안위1~2급자격증상,량조차이무통계학의의(P>0.05)。량조각막상피완전유합시간위3~5d,기중실험조평균위(3.75±0.72)d,대조조평균위(3.54±0.85)d,량조차이무통계학의의(P>0.05)。3~5d적경시,실험조유382안(94.1%),대조조유396안(97.5%),각막상피유합량호。술후3개월검사,실험조술후시력만의위390안(93.6%),대조조위344안(84.7%),량조차이유통계학의의(P<0.05)。술후3개월검사,굴광도교술후3개월시회퇴초과0.50D,사렬매소조유22안(5.4%),대조조유46안(11.3%)。술후3월검사,실험조유336안(82.8%)위0급haze,대조조유252안(62.1%)위0급haze,량조차이유통계학의의(P<0.05)。결론재준분자교정근시수술중,일차성응용0.2g/L사렬매소가이감경술후haze적반응,감소술후시력적회퇴,무명현불량반응。
Objective The explore the therapeutic effectiveness and safety of mitomycin C in eximer laser epi-thelial keratomileusis (ELEK) .Methods 812 eyes were divided into two groups ,including experiment group with mitomycin C application and control group without mitomycin C application ,and irritative symptom ,growth of epi-thelium ,postoperative visual acuity ,optometry ,intraocular pressure and haze conditions were compared between the two groups .Results Operation of all cases were accomplished as expected .During follow-up from 3 months to 3 years ,the irritation in both groups was slight ,most of which happened on the 1st day after surgery ,improve on the 2nd day .On 3rd day after surgery ,40 eyes in experiment group and 38 eyes in control group were with I - Ⅱ level irritative symptoms ,and the difference was not significant (P>0 .05) .The average time of healing of the epithelium in experiment group and control group were (3 .75 ± 0 .72) and (3 .54 ± 0 .85)d ,and the difference was not signifi-cant (t=1 .522 ,P>0 .05) .After 3 to 5 days ,the lens could be taken off ,and 382 eyes (94 .1% ) in experiment group and 396 eyes (97 .5% ) in control group were with satisfactory healing of epithelium .Three months after oper-ative ,390 eyes (93 .6% ) in experiment group were with satisfactory visual acuity ,higher than control group [344 eyes (84 .7% ) ,P<0 .5] .Compared with before surgery ,diopter of 22 eyes (5 .4% ) in experiment group ,detected three months after surgery ,returned -0 .50D ,and 46 eyes (11 .3% ) in control group were with the same changes . Besides ,there were 334 eyes (82 .3% ) of 0 level haze in experiment group ,higher than control group [250 eyes (61 .6% ) , P<0 .05] .Conclusion Application of 0 .2 g/L mitomycin C at once in ELEK operation could reduce the postoperative haze-reaction and the return of the visual acuity ,meanwhile without obvious side effect .